Scepter Holdings’s Biogen BIIB Stock Holding History

Scepter Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,000	Closed	-$946K	–	94
2014 Q2	$946K	Buy	+3,000	New	+$903K	0.24%	68

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Scepter Holdings's BIIB Position: Q3 2014 in Review

Scepter Holdings sold out of Biogen (BIIB) in Q3 2014, closing a stake of 3,000 shares — an estimated $946K sold.

Scepter Holdings first reported a position in BIIB in Q2 2014 and held it in 1 quarter. The position peaked at $946K in Q2 2014. 818 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

Scepter Holdings reported no remaining Biogen position as of Q3 2014 after selling out during the quarter.
Scepter Holdings sold 3,000 Biogen shares in Q3 2014, an estimated $946K.
Scepter Holdings first reported a position in Biogen in Q2 2014 and held it in 1 quarter.
Scepter Holdings's Biogen position peaked at $946K in Q2 2014.
818 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on Scepter Holdings's 13F filing for Q3 2014, filed 13 Nov 2014.